Ward Shane Insider Trades

Insider Trading History

Track insider trading activity for Ward Shane. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Cidara Therapeutics
Cidara Therapeutics CDTX
COO & CLO
Holding Value $0 0 shares
Last Trade
Jan 07, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$53.5M 241,829 shares
$221.38
$221.38
Cidara Therapeutics
Cidara Therapeutics CDTX
COO & CLO
Holding Value $5.45M 24,633 shares
Last Trade
Dec 10, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.3M 15,041 shares
$219.60
$221.38
Cidara Therapeutics
Cidara Therapeutics CDTX
COO & CLO
Holding Value $7.66M 34,592 shares
Last Trade
Dec 10, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.19M 9,959 shares
$219.81
$221.38
Cidara Therapeutics
Cidara Therapeutics CDTX
COO & CLO
Holding Value $1.37M 6,207 shares
Last Trade
Dec 10, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.19M 9,959 shares
$219.81
$221.38
Cidara Therapeutics
Cidara Therapeutics CDTX
COO & CLO
Holding Value $5.54M 25,033 shares
Last Trade
Dec 10, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.19M 9,959 shares
$220.08
$221.38
Cidara Therapeutics
Cidara Therapeutics CDTX
COO & CLO
Holding Value $11.1M 50,000 shares
Last Trade
Mar 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.08M 50,000 shares
$21.54
$221.38
Cidara Therapeutics
Cidara Therapeutics CDTX
COO & CLO
Holding Value $3.25M 14,674 shares
Last Trade
Mar 11, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$36.5k 1,664 shares
$21.96
$221.38
Cidara Therapeutics
Cidara Therapeutics CDTX
COO & CLO
Holding Value $30M 135,540 shares
Last Trade
Sep 30, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.46M 135,540 shares
$10.75
$221.38
Cidara Therapeutics
Cidara Therapeutics CDTX
COO & CLO
Holding Value $70.6M 318,770 shares
Last Trade
Mar 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.43M 250,000 shares
$13.70
$221.38
Cidara Therapeutics
Cidara Therapeutics CDTX
COO & CLO
Holding Value $44M 198,770 shares
Last Trade
Mar 11, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$271k 20,473 shares
$13.22
$221.38
Cidara Therapeutics
Cidara Therapeutics CDTX
COO & CLO
Holding Value $56.1M 253,333 shares
Last Trade
Mar 27, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.12M 253,333 shares
$20.20
$221.38
Cidara Therapeutics
Cidara Therapeutics CDTX
COO & CLO
Holding Value $18.7M 84,576 shares
Last Trade
Mar 13, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$150k 4,329 shares
$34.60
$221.38
Cidara Therapeutics
Cidara Therapeutics CDTX
CHIEF LEGAL OFFICER
Holding Value $15.5M 70,000 shares
Last Trade
Mar 31, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.17M 70,000 shares
$16.65
$221.38
Cidara Therapeutics
Cidara Therapeutics CDTX
CHIEF LEGAL OFFICER
Holding Value $17.9M 80,905 shares
Last Trade
Mar 31, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$385k 23,122 shares
$16.65
$221.38
Cidara Therapeutics
Cidara Therapeutics CDTX
CHIEF LEGAL OFFICER
Holding Value $55.3M 250,000 shares
Last Trade
Aug 25, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.8M 250,000 shares
$43.20
$221.38
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Sr VP And Chief Legal SO
Holding Value $141 1,879 shares
Last Trade
May 29, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$816 107 shares
$7.63
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Sr. VP And General Counsel
Holding Value $1.64k 21,864 shares
Last Trade
Apr 08, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$212k 43,728 shares
$4.85
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Sr. VP And General Counsel
Holding Value $30.7k 410,000 shares
Last Trade
Feb 03, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.58M 410,000 shares
$13.60
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Sr. VP And General Counsel
Holding Value $1.37k 18,294 shares
Last Trade
Aug 29, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$96k 8,000 shares
$12.00
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Sr. VP And General Counsel
Holding Value $3.37k 45,000 shares
Last Trade
Jun 11, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.68M 90,000 shares
$18.70
$0.07

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up